Publications
Metformin is Protective Against the Development of Mood Disorders
J Lake, C Bortolasci, A Stuart, J Pasco, S Kidnapillai, B Spolding, T Truong, B Panizzutti, Z Liu, O Dean, T Crowley, M Richardson, J Kim, M Berk, L Williams, K Walder
(2023), Vol. 56, pp. 25-31, Pharmacopsychiatry, Germany, C1
Common effects of bipolar disorder medications on expression quantitative trait loci genes
T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, B Watmuff, J Kim, O Dean, M Richardson, M Berk, K Walder
(2022), Vol. 150, pp. 105-112, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1
Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Zoe Liu, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Craig Smith, Olivia Dean, Jee Kim, Michael Berk, Ken Walder
(2022), Vol. 13, pp. 1-12, Frontiers in Pharmacology, Lausanne, Switzerland, C1
Effects of psychotropic drugs on ribosomal genes and protein synthesis
Zoe Liu, Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Courtney Swinton, Jee Kim, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Olivia Dean, Sean McGee, Michael Berk, Ken Walder
(2022), Vol. 23, pp. 7180-7180, International Journal of Molecular Sciences, Basel, Switzerland, C1
Integrative analyses of transcriptomes to explore common molecular effects of antipsychotic drugs
Trang Truong, Chiara Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Bruna Panizzutti, Zoe Liu, Jee Kim, Olivia Dean, Mark Richardson, Michael Berk, Ken Walder
(2022), Vol. 23, pp. 7508-7508, International Journal of Molecular Sciences, Basel, Switzerland, C1
Effects of psychoactive drugs on cellular bioenergetic pathways
C Bortolasci, B Spolding, S Kidnapillai, M Richardson, N Vasilijevic, S Martin, L Gray, S McGee, M Berk, K Walder
(2021), Vol. 22, pp. 79-93, World Journal of Biological Psychiatry, England, C1
Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, V Carr, M Berk, K Walder, M Green
(2021), Vol. 105, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1
B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, G Morris, L Gray, J Kim, O Dean, M Berk, K Walder
(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1
Biological mechanism(S) underpinning the association between antipsychotic drugs and weight gain
B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, L Gray, J Kim, O Dean, M Berk, K Walder
(2021), Vol. 10, Journal of Clinical Medicine, Switzerland, C1
L Arancini, M Mohebbi, M Berk, O Dean, C Bortolasci, B Spolding, R Zazula, S Dodd
(2021), Vol. 53, pp. 120-126, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1
The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
S Kidnapillai, C Bortolasci, M Udawela, B Panizzutti, B Spolding, T Connor, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, E Scarr, M Leboyer, B Dean, M Berk, K Walder
(2020), Vol. 21, pp. 775-783, World Journal of Biological Psychiatry, England, C1
S Kidnapillai, B Wade, C Bortolasci, B Panizzutti, B Spolding, T Connor, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder
(2020), Vol. 34, pp. 370-379, Journal of Psychopharmacology, United States, C1
Transcriptional effects of psychoactive drugs on genes involved in neurogenesis
C Bortolasci, B Spolding, S Kidnapillai, T Connor, T Truong, Z Liu, B Panizzutti, M Richardson, L Gray, M Berk, O Dean, K Walder
(2020), Vol. 21, pp. 1-19, International Journal of Molecular Sciences, Switzerland, C1
Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, M Berk, V Carr, K Walder, M Green
(2019), Vol. 49, pp. 2736-2744, Psychological Medicine, England, C1
S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder
(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1
Mechanisms underpinning the polypharmacy effects of medications in psychiatry
C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder
(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1
A Kaspi, I Khurana, M Ziemann, T Connor, B Spolding, P Zimmet, K Walder, A El-Osta
(2018), Vol. 62, Molecular Nutrition and Food Research, Germany, C1
K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean
(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1
I Khurana, A Kaspi, M Ziemann, T Block, T Connor, B Spolding, A Cooper, P Zimmet, A El-Osta, K Walder
(2017), Vol. 49, pp. S103-S104, Pathology, Amsterdam, The Netherlands, C1
I Khurana, A Kaspi, M Ziemann, T Block, T Connor, B Spolding, A Cooper, P Zimmet, A El-Osta, K Walder
(2016), Vol. 40, pp. 1079-1088, International Journal of Obesity, England, C1
J Eastwood, M Berg, B Spolding, K Buchanan, A Bennett, K Walder
(2015), Vol. 63, pp. 1-8, Australian journal of zoology, Clayton, Vic., C1
Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli Sand Rat)
B Spolding, T Connor, C Wittmer, L Abreu, A Kaspi, M Ziemann, G Kaur, A Cooper, S Morrison, S Lee, A Sinclair, Y Gibert, J Trevaskis, J Roth, A El-Osta, R Standish, K Walder
(2014), Vol. 9, pp. 1-7, PLoS one, San Francisco, Calif., C1
Non-referenced genome assembly from epigenomic short-read data
A Kaspi, M Ziemann, S Keating, I Khurana, T Connor, B Spolding, A Cooper, R Lazarus, K Walder, P Zimmet, A El-Osta
(2014), Vol. 9, pp. 1329-1338, Epigenetics, United States, C1
Genetic variation associated with hypersensitivity to mercury.
D Austin, B Spolding, S Gondalia, K Shandley, E Palombo, S Knowles, K Walder
(2014), Vol. 21, pp. 236-241, Toxicology International, India, C1-1
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo
N Konstantopoulos, J Molero, S McGee, B Spolding, T Connor, M de Vries, S Wanyonyi, R Fahey, S Morrison, C Swinton, S Jones, A Cooper, L Garcia-Guerra, V Foletta, G Krippner, S Andrikopoulos, K Walder
(2012), Vol. 61, pp. 2146-2154, Diabetes, Alexandria, Va., C1
Funded Projects at Deakin
Other Public Sector Funding
Determination of RIPTAC bioavailability, pharmacokinetics and distribution
Prof Ken Walder, Mr Timothy Connor, Ms Briana Randall
DPI Grant - Research - Department of Primary Industries - Victoria
- 2011: $12,000
Supervisions
No completed student supervisions to report